| Literature DB >> 22162937 |
Kazutaka Noda1, Masatomi Ikusaka, Yoshiyuki Ohira, Toshihiko Takada, Tomoko Tsukamoto.
Abstract
OBJECTIVE: Patient medical history is important for making a diagnosis of causes of dizziness, but there have been no studies on the diagnostic value of individual items in the history. This study was performed to identify and validate useful questions for suspecting a diagnosis of benign paroxysmal positional vertigo (BPPV).Entities:
Keywords: benign paroxysmal positional vertigo; diagnosis; likelihood ratio; prediction rules; screening
Year: 2011 PMID: 22162937 PMCID: PMC3233377 DOI: 10.2147/IJGM.S27536
Source DB: PubMed Journal: Int J Gen Med ISSN: 1178-7074
Characteristics of the subjects (derivation and validation sets)
| Derivation set (N = 145) | Validation set (N = 61) | |
|---|---|---|
| Mean age, y ± SD | 45.9 ± 17.4 | 48.7 ± 17.1 |
| Male, n (%) | 49 (33.8) | 25(41) |
| Peripheral disease | 47 (32) | 24 (39) |
| DHT+ BPPV | 12 (8.3) | 6 (10) |
| Mean age, y ± SD | 57.0 ± 17.6 | 54.7 ± 16.3 |
| Male | 6 (50) | 1 (17) |
| DHT− BPPV | 30 (20.7) | 14 (23) |
| Meniere’s disease | 3 (2.1) | 1 (1.6) |
| Vestibular neuritis | 2 (1.4) | 3 (4.9) |
| Psychogenic disorders | 56 (39) | 18 (30) |
| Depressive disorder | 24 (17) | 5 (8.2) |
| Somatoform disorder | 12 (8.3) | 1 (1.6) |
| Adjustment disorder | 6 (4.1) | 5 (8.2) |
| Panic disorder | 5 (3.4) | 2 (3.3) |
| Anxiety disorder | 3 (2.1) | 3 (4.9) |
| Hypochondriasis | 2 (1.4) | 1 (1.6) |
| Others | 4 (2.8) | 1 (1.6) |
| Central diseases | 8 (5.5) | 3 (4.9) |
| Migraine | 3 (2.1) | 1 (1.6) |
| Transient ischemic attack | 2 (3.3) | |
| Others | 5 (3.4) | |
| Others | 19 (13) | 9 (15) |
| Orthostatic hypotension | 5 (3.4) | 1 (1.6) |
| Combined sensory disorder | 3 (2.1) | 1 (1.6) |
| Arrhythmia | 2 (1.4) | |
| Anemia | 2 (1.4) | |
| Drug-induced | 2 (1.4) | |
| Cervical vertigo | 2 (1.4) | |
| Overwork | 2 (1.4) | 1 (1.6) |
| Others | 1 (0.7) | 6 (9.8) |
| Unknown diagnosis | 15 (10) | 8 (13) |
| Patients requiring consultation with specialists, n (%) | 56 (39) | 15 (25) |
Notes: The derivation set is a group used for development of the predictive model, and the validation set is a group used for validation of the model.
Percentage of patients in each set; the total exceeds 100% because a patient had multiple diseases;
percentage of DHT+ BPPV patients in each set;
“others” includes the following diseases (n): conversion disorder (1), paranoia (1), acute stress disorder (1), and factitious disorder (1) in the derivation set; phobia (1) in the validation set;
“others” includes the following diseases (n): cerebral infarction (1), acoustic neuroma (1), epilepsy (1), Adie’s syndrome (1), and alcoholic cerebellar ataxia (1) in the derivation set;
“others” includes the following diseases: vasovagal reflex (1) in the derivation set; vasovagal reflex (1), sleep apnea syndrome (1), sleep deprivation (1), cytomegalovirus infection (1), dehydration (1) and deconditioning (1) in the validation set.
Abbreviations: SD, standard deviation; BPPV, benign paroxysmal positional vertigo; DHT+, positive Dix–Hallpike test; DHT−, negative Dix–Hallpike test.
Performance characteristics of individual items
| Sensitivity (95% CI) | Specificity (95% CI) | Positive likelihood ratio (95% CI) | Negative likelihood ratio (95% CI) | |
|---|---|---|---|---|
| Sudden onset | 0.92 (0.76–1.00) | 0.33 (0.25–0.41) | 1.36 (1.33–1.39) | 0.26 (0.04–1.59) |
| Recurrence | 0.83 (0.62–1.00) | 0.29 (0.21–0.37) | 1.18 (1.13–1.22) | 0.57 (0.24–1.34) |
| Diurnal fluctuation | 0.67 (0.40–0.93) | 0.50 (0.41–0.59) | 1.33 (1.21–1.47) | 0.67 (0.47–0.94) |
| Duration of dizziness ≤15 seconds | 0.42 (0.14–0.70) | 0.84 (0.78–0.90) | 2.64 (1.94–3.59) | 0.69 (0.61–0.78) |
| Spinning sensation (rotation) | 0.92 (0.76–1.00) | 0.65 (0.57–0.73) | 2.63 (2.52–2.74) | 0.13 (0.02–0.78) |
| Onset when turning over in bed | 0.75 (0.51–1.00) | 0.77 (0.69–0.84) | 3.23 (2.90–3.58) | 0.33 (0.20–0.53) |
| Onset when standing up | 0.75 (0.51–1.00) | 0.52 (0.44–0.61) | 1.57 (1.46–1.69) | 0.48 (0.29–0.79) |
| Onset when looking up | 0.42 (0.14–0.70) | 0.77 (0.70–0.85) | 1.84 (1.39–2.44) | 0.75 (0.67–0.85) |
| Onset when looking down | 0.50 (0.22–0.78) | 0.71 (0.63–0.79) | 1.73 (1.41–2.11) | 0.70 (0.59–0.83) |
| Deafness | 0.08 (0–0.24) | 0.95 (0.92–0.99) | 1.82 (0.22–14.98) | 0.96 (0.95–0.98) |
| Nausea and/or vomiting | 0.67 (0.40–0.93) | 0.60 (0.51–0.68) | 1.65 (1.49–1.83) | 0.56 (0.40–0.78) |
| Double vision | 0.08 (0–0.24) | 0.94 (0.90–0.98) | 1.35 (0.18–10.28) | 0.98 (0.96–0.99) |
| Faintness | 0.25 (0.01–0.50) | 0.82 (0.76–0.89) | 1.40 (0.80–2.45) | 0.91 (0.86–0.97) |
| History of diabetes mellitus | 0.08 (0–0.24) | 0.98 (0.95–1.00) | 3.69 (0.32–42.19) | 0.94 (0.92–0.95) |
| Loss of enjoyment | 0.83 (0.62–1.00) | 0.35 (0.27–0.43) | 1.28 (1.23–1.33) | 0.48 (0.20–1.11) |
Abbreviation: CI, confidence interval.
Results of binomial logistic regression analysis
| Variable | Regression coefficient | Significant probability | Odds ratio (95% CI) | Point |
|---|---|---|---|---|
| Duration of dizziness ≤15 seconds | 1.47 | 0.028 | 4.36 (1.18–16.19) | 1 |
| Onset when turning over in bed | 2.32 | 0.001 | 10.17 (2.49–41.63) | 2 |
| Constant | −4.05 | <0.001 |
Notes: Model chi-square test, P < 0.01. Predictive value = 91.0%.
Calculated based on regression coefficients.
Abbreviation: CI, confidence interval.
Performance of the BPPV prediction model
| Number of appropriate items (prediction score) | ||||
|---|---|---|---|---|
| 0 | 1 | 2 | 3 | |
| Derivation set (N = 141), n (%) | ||||
| DHT + BPPV | 1 (1) | 2 (8) | 4 (15) | 5 (42) |
| Others | 75 (99) | 24 (92) | 23 (85) | 7 (58) |
| Validation set (N = 61), n (%) | ||||
| DHT + BPPV | 1 (3) | 0 (0) | 2 (13) | 3 (38) |
| Others | 30 (97) | 7 (100) | 13 (87) | 5 (63) |
Notes: With a threshold of 0.5, the positive predictive value (PPV) and negative predictive value (NPV) for the derivation set were 16.9% and 98.7%, respectively, and those for the validation set were 16.7% and 96.8%, respectively. With a threshold of 1.5, PPV and NPV for the derivation set were 23.1% and 97.1%, respectively, and those for the validation set were 21.7% and 97.4%, respectively. With a threshold of 2.5, PPV and NPV for the derivation set were 41.7% and 94.6%, respectively, and those for the validation set were 37.5% and 94.3%, respectively.
Others include DHT − BPPV and non-BPPV.
Abbreviations: BPPV, benign paroxysmal positional vertigo; DHT+, positive Dix– Hallpike test; DHT−, negative Dix–Hallpike test.
Performance characteristics of the two predictive items* for DHT + BPPV in the combined derivation and validation sets
| Sensitivity | Specificity | LR | |
|---|---|---|---|
| Positivity of both | 0.44 (0.21–0.67) | 0.93 (0.90–0.97) | 6.81 (5.11–9.10) |
| Positivity of only one | 0.44 (0.21–0.67) | 0.64 (0.57–0.71) | 1.22 (1.05–1.43) |
| Positivity of none | 0.11 (0–0.26) | 0.43 (0.36–0.50) | 0.19 (0.08–0.47) |
Note: These are “duration of dizziness ≤15 seconds” and “onset when turning over in bed.”
Abbreviations: BPPV, benign paroxysmal positional vertigo; DHT+, positive Dix– Hallpike test; LR, likelihood ratio.